Key considerations to reduce or address respondent burden in patient-reported outcome (PRO) data collection

Olalekan Lee Aiyegbusi; Jessica  Roydhouse; Samantha Cruz Rivera; Paul  Kamudoni; Peter  Schache; Roger  Wilson; Richard Stephens; Melanie Calvert

doi:10.1038/s41467-022-33826-4

Key considerations to reduce or address respondent burden in patient-reported outcome (PRO) data collection

Olalekan Lee Aiyegbusi^*, Jessica Roydhouse, Samantha Cruz Rivera, Paul Kamudoni, Peter Schache, Roger Wilson, Richard Stephens, Melanie Calvert

^*Corresponding author for this work

Applied Health Research

Research output: Contribution to journal › Comment/debate › peer-review

51 Downloads (Pure)

Abstract

Patient-reported outcomes (PROs) are used in clinical trials to provide evidence of the benefits and risks of interventions from a patient perspective and to inform regulatory decisions and health policy. The collection of PROs in routine practice can facilitate monitoring of patient symptoms; identification of unmet needs; prioritisation and/or tailoring of treatment to the needs of individual patients and inform value-based healthcare initiatives. However, respondent burden needs to be carefully considered and addressed to avoid high rates of missing data and poor reporting of PRO results, which may lead to poor quality data for regulatory decision making and/or clinical care.

Original language	English
Article number	6026
Pages (from-to)	6026
Number of pages	8
Journal	Nature Communications
Volume	13
DOIs	https://doi.org/10.1038/s41467-022-33826-4
Publication status	Published - 12 Oct 2022

Bibliographical note

Keywords

/692/308/409
Perspective
/692/308/2779
/692/700/784
perspective
Delivery of Health Care
Humans
Data Collection
Health Policy
Patient Reported Outcome Measures

ASJC Scopus subject areas

General
General Physics and Astronomy
General Chemistry
General Biochemistry,Genetics and Molecular Biology

Access to Document

10.1038/s41467-022-33826-4Licence: Creative Commons: Attribution (CC BY)

AiyegbusiO2022KeyFinal published version, 683 KBLicence: Creative Commons: Attribution (CC BY)

Cite this

@article{3cd64902920d4c66994a7797be7fb52f,

title = "Key considerations to reduce or address respondent burden in patient-reported outcome (PRO) data collection",

abstract = "Patient-reported outcomes (PROs) are used in clinical trials to provide evidence of the benefits and risks of interventions from a patient perspective and to inform regulatory decisions and health policy. The collection of PROs in routine practice can facilitate monitoring of patient symptoms; identification of unmet needs; prioritisation and/or tailoring of treatment to the needs of individual patients and inform value-based healthcare initiatives. However, respondent burden needs to be carefully considered and addressed to avoid high rates of missing data and poor reporting of PRO results, which may lead to poor quality data for regulatory decision making and/or clinical care.",

keywords = "/692/308/409, Perspective, /692/308/2779, /692/700/784, perspective, Delivery of Health Care, Humans, Data Collection, Health Policy, Patient Reported Outcome Measures",

author = "Aiyegbusi, {Olalekan Lee} and Jessica Roydhouse and {Cruz Rivera}, Samantha and Paul Kamudoni and Peter Schache and Roger Wilson and Richard Stephens and Melanie Calvert",

note = "{\textcopyright} 2022. The Author(s).",

year = "2022",

month = oct,

day = "12",

doi = "10.1038/s41467-022-33826-4",

language = "English",

volume = "13",

pages = "6026",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Springer",

}

TY - JOUR

T1 - Key considerations to reduce or address respondent burden in patient-reported outcome (PRO) data collection

AU - Aiyegbusi, Olalekan Lee

AU - Roydhouse, Jessica

AU - Cruz Rivera, Samantha

AU - Kamudoni, Paul

AU - Schache, Peter

AU - Wilson, Roger

AU - Stephens, Richard

AU - Calvert, Melanie

PY - 2022/10/12

Y1 - 2022/10/12

N2 - Patient-reported outcomes (PROs) are used in clinical trials to provide evidence of the benefits and risks of interventions from a patient perspective and to inform regulatory decisions and health policy. The collection of PROs in routine practice can facilitate monitoring of patient symptoms; identification of unmet needs; prioritisation and/or tailoring of treatment to the needs of individual patients and inform value-based healthcare initiatives. However, respondent burden needs to be carefully considered and addressed to avoid high rates of missing data and poor reporting of PRO results, which may lead to poor quality data for regulatory decision making and/or clinical care.

AB - Patient-reported outcomes (PROs) are used in clinical trials to provide evidence of the benefits and risks of interventions from a patient perspective and to inform regulatory decisions and health policy. The collection of PROs in routine practice can facilitate monitoring of patient symptoms; identification of unmet needs; prioritisation and/or tailoring of treatment to the needs of individual patients and inform value-based healthcare initiatives. However, respondent burden needs to be carefully considered and addressed to avoid high rates of missing data and poor reporting of PRO results, which may lead to poor quality data for regulatory decision making and/or clinical care.

KW - /692/308/409

KW - Perspective

KW - /692/308/2779

KW - /692/700/784

KW - perspective

KW - Delivery of Health Care

KW - Humans

KW - Data Collection

KW - Health Policy

KW - Patient Reported Outcome Measures

UR - http://www.scopus.com/inward/record.url?scp=85139802828&partnerID=8YFLogxK

U2 - 10.1038/s41467-022-33826-4

DO - 10.1038/s41467-022-33826-4

M3 - Comment/debate

C2 - 36224187

SN - 2041-1723

VL - 13

SP - 6026

JO - Nature Communications

JF - Nature Communications

M1 - 6026

ER -

Key considerations to reduce or address respondent burden in patient-reported outcome (PRO) data collection

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

Access to Document

Fingerprint

Cite this